Akatsu et al. reported that TGF-β and FGF-2 antagonized or cooperated with each other to control the formation of cancer-restraining CAFs and cancer-promoting CAFs, respectively, and that TGF-β and FGF-2 determine CAF characteristics in the tumor microenvironment [34]. The gene discussed is TGFB1; the disease is neoplasm.